Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-12-26 9:00 pm Purchase |
2024-12-20 | 13D | Fate Therapeutics, Inc. FATE |
Redmile Group LLC | 17,816,634 14.900% |
197,539 (+1.12%) |
Filing History |
| 2024-11-14 7:50 pm Sale |
2024-09-30 | 13G | Fate Therapeutics, Inc. FATE |
Point72 Asset Management, L.P. | 0 0.000% |
-4,945,146 (Position Closed) |
Filing History |
| 2024-11-08 5:31 pm Unchanged |
2024-09-30 | 13G | Fate Therapeutics, Inc. FATE |
BLACKROCK INC BLK |
10,473,250 9.200% |
0 (Unchanged) |
Filing History |
| 2024-10-25 9:37 pm Purchase |
2024-10-10 | 13G | Fate Therapeutics, Inc. FATE |
Boxer Capital Management LLC | 4,960,910 4.400% |
4,960,910 (New Position) |
Filing History |
| 2024-10-21 4:11 pm Sale |
2024-09-30 | 13G | Fate Therapeutics, Inc. FATE |
BLACKROCK INC BLK |
10,473,250 9.200% |
-739,566 (-6.60%) |
Filing History |
| 2024-03-25 5:15 pm Purchase |
2024-03-21 | 13D | Fate Therapeutics, Inc. FATE |
Redmile Group LLC | 17,619,095 14.900% |
2,569,256 (+17.07%) |
Filing History |
| 2024-02-13 5:04 pm Sale |
2023-12-29 | 13G | Fate Therapeutics, Inc. FATE |
The Vanguard Group | 9,293,363 9.430% |
-642,679 (-6.47%) |
Filing History |
| 2024-02-12 6:06 pm Purchase |
2024-01-31 | 13G | Fate Therapeutics, Inc. FATE |
Boxer Capital LLC | 6,171,000 6.300% |
6,171,000 (New Position) |
Filing History |
| 2024-02-09 6:19 pm Sale |
2024-02-07 | 13G | Fate Therapeutics, Inc. FATE |
Capital World Investors | 0 0.000% |
-5,591,517 (Position Closed) |
Filing History |
| 2024-01-25 4:19 pm Purchase |
2024-01-24 | 13G | Fate Therapeutics, Inc. FATE |
Point72 Asset Management, L.P. | 4,945,146 5.000% |
4,945,146 (New Position) |
Filing History |
| 2024-01-24 09:46 am Purchase |
2023-12-31 | 13G | Fate Therapeutics, Inc. FATE |
BLACKROCK INC BLK |
11,212,816 11.400% |
1,486,921 (+15.29%) |
Filing History |
| 2024-01-22 1:46 pm Sale |
2023-12-31 | 13G | Fate Therapeutics, Inc. FATE |
STATE STREET CORP STT |
1,861,919 1.890% |
-410,006 (-18.05%) |
Filing History |
| 2023-12-28 4:53 pm Sale |
2023-12-26 | 13D | Fate Therapeutics, Inc. FATE |
Redmile Group LLC | 15,049,839 14.900% |
-21,257 (-0.14%) |
Filing History |
| 2023-10-10 11:16 am Sale |
2023-09-30 | 13G | Fate Therapeutics, Inc. FATE |
STATE STREET CORP STT |
2,271,925 2.310% |
-11,717,507 (-83.76%) |
Filing History |
| 2023-05-10 09:16 am Purchase |
2023-04-30 | 13G | Fate Therapeutics, Inc. FATE |
STATE STREET CORP STT |
13,989,432 14.240% |
8,053,973 (+135.69%) |
Filing History |
| 2023-04-19 5:15 pm Purchase |
2023-04-13 | 13D | Fate Therapeutics, Inc. FATE |
Redmile Group LLC | 15,071,096 14.900% |
2,077,208 (+15.99%) |
Filing History |
| 2023-03-22 4:15 pm Purchase |
2023-03-16 | 13G | Fate Therapeutics, Inc. FATE |
MILLENNIUM MANAGEMENT LLC | 1,696,431 1.700% |
1,696,431 (New Position) |
Filing History |
| 2023-03-10 07:59 am Purchase |
2023-02-28 | 13G | Fate Therapeutics, Inc. FATE |
The Vanguard Group | 9,936,042 10.120% |
1,963,491 (+24.63%) |
Filing History |
| 2023-02-13 2:49 pm Purchase |
2023-02-14 | 13G | Fate Therapeutics, Inc. FATE |
Capital World Investors | 5,591,517 5.800% |
5,591,517 (New Position) |
Filing History |
| 2023-02-09 11:19 am Purchase |
2022-12-30 | 13G | Fate Therapeutics, Inc. FATE |
The Vanguard Group | 7,972,551 8.200% |
296,764 (+3.87%) |
Filing History |